Press release
Newly Published Visiongain Report: Global Antidepressant and Anti-Anxiety Drugs Market 2019-2029
Your guide to your industry
Purchase the full report or download free sample pages: https://www.visiongain.com/report/global-antidepressant-and-anti-anxiety-drugs-market-2019-2029/
The global antidepressant and Anti-anxiety drugs market is estimated to have reached $12.16bn in 2018. In 2018, the SSRIs segment held 26% of the global antidepressant and anti-anxiety drugs market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 213-page report you will receive 73 tables and 92 figures- all unavailable elsewhere.
The 213-page report provides clear detailed insight into the global antidepressant and anti-anxiety drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
o Global antidepressant and anti-anxiety drugs market forecasts from 2019-2029
o Our investigation shows forecasts to 2029 for the following sub-market by drug class:
o Serotonin Reuptake Inhibitors (SSRIs)
o Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
o Atypical Antipsychotics
o Tricyclic Antidepressants (TCAs)
o Serotonin Antagonist and Reuptake Inhibitors (SARIs)
o Benzodiazepines
o Monoamine Oxidase Inhibitors (MAOIs)
o Others
o Our investigation shows forecasts to 2029 for the following submarket by indication:
o Major Depressive Disorder (MDD)
o General Anxiety Disorder (GAD)
o Panic Disorder (PD)
o Obsessive Compulsive Disorder (OCD)
o Others
o Our investigation shows forecasts to 2029 for the selected leading drugs:
o Abilify
o Abilify Maintena
o Brintellix/Trintellix
o Cipralex/Lexapro
o Cymbalta
o Invega Sustenna/ Xeplion/Trinza/Trevicta
o Lamictal
o Rexulti
o Risperdal Consta
o Zyprexa
o This report provides individual revenue forecasts to 2029 for these regional and national markets:
o North America: the US, Canada
o Europe: the UK, Germany, Spain, France, Italy, Russia, Rest of Europe
o Asia-Pacific: Japan, China, India, South Korea, Rest of Asia-Pacific
o RoW: Brazil, Mexico, Russia, South Africa, Rest of RoW
o This report also provides discussion and qualitative analysis on:
o Factors that drive and restrain the global antidepressant and Anti-anxiety drugs market.
o Antidepressant drugs pipeline analysis
o Anti-anxiety drugs pipeline analysis
o This report discusses the selected leading companies:
o Allergan plc.
o AstraZeneca plc.
o Eli Lilly and Company
o GlaxoSmithKline plc.
o H. Lundbeck A/S
o Johnson & Johnson
o Otsuka Pharmaceutical Co., Ltd.
o Pfizer Inc.
o Pfizer Inc.
o Takeda Pharmaceutical Company Ltd.
o Valeant Pharmaceuticals
o Key Questions Answered:
o This report provides in-depth analysis of the antidepressant and anti-anxiety drugs market, identifying the latest trends and forecasting its growth and development over the coming 10 years.
o The study addresses scope of the market in 2018 and assesses commercial drivers and restraints.
o Through reading this report you will gain revenue forecasts from 2018 to 2029 for the overall world market and its leading sub-markets, as well as regional and national markets.
o This report provides revenue forecast for the leading antidepressant and anti-anxiety drugs from 2018 to 2019
o Identify drug development trends that will affect market participants from 2018 to 2029.
o See discussions of companies developing, manufacturing, and marketing antidepressant and ant-anxiety drugs, exploring products, technologies, R&D, partnerships, M&A and outlooks.
Visiongain's study is intended for anyone requiring commercial analyses for the antidepressant and anti-anxiety drugs market. You find data, trends and predictions.
Buy our report today: Global Antidepressant and Anti-anxiety Drugs Market 2019-2029: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Atypical Antipsychotics, Tricyclic Antidepressants (TCAs), Serotonin Antagonist and Reuptake Inhibitors (SARIs), Benzodiazepines; Monoamine Oxidase Inhibitors (MAOIs), Major Depressive Disorder (MDD), General Anxiety Disorder (GAD), Panic Disorder (PD), Obsessive Compulsive Disorder (OCD), Others.
Related Reports:
Global Surgical Sutures Market 2020-2030: https://www.visiongain.com/report/global-surgical-sutures-market-2020-2030/
Medical Robotic Systems Market Report 2020-2030:
https://www.visiongain.com/report/medical-robotic-systems-market-report-2020-2030/
Medical Oxygen Concentrators Market Report 2020-2030: https://www.visiongain.com/report/medical-oxygen-concentrators-market-report-2020-2030/
For more Pharma reports, visit our website:
https://www.visiongain.com/industries/pharma/
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Visiongain Limited
Airport House
Purley Way
Surrey
London
CR0 0XZ
United Kingdom
About Visiongain:
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Newly Published Visiongain Report: Global Antidepressant and Anti-Anxiety Drugs Market 2019-2029 here
News-ID: 1957574 • Views: …
More Releases from visiongain
Can Coatings Market Research Report Up to 2031
Visiongain has published a new report on Can Coatings Market Report to 2031: Segmentation by Type (Epoxy, Oleoresin, Vinyl, Phenolic, Acrylic, Polyester, Polyolefin, Additives, Other Type) Segmentation by Coating Technologies (Conventional solvent borne coatings, High-solids coatings, Waterborne coatings, Ultraviolet radiation-cured (UV-cured) coatings, Powder coatings, Other Technologies) Segmentation by Application (Food Can, Beverage Can, General Line Can, Aerosol Can, Others, Other Application) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped,…
Automatic Number Plate Recognition (ANPR) System Market Report Up to 2031
Visiongain has published a new report on Automatic Number Plate Recognition (ANPR) System Market Report to 2031: Forecasts by component (Hardware, Software, Services), by type (Fixed ANPR Systems, Portable ANPR Systems), by application (Traffic Management, Law Enforcement, Electronic Toll Collection, Others). PLUS Profiles of Leading Automatic Number Plate Recognition System Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/anpr-system-market/#download_sampe_div
Automatic number plate…
Automatic Labelling Machine Market Report Up to 2031
Visiongain has published a new report on Automatic Labelling Machine Market Report to 2031: Forecasts by type (Stretch Sleeve Labelers, Shrink-Sleeve Labelers, Glue-based Labelers, Others), by industry vertical (Consumer Goods, Food & Beverages, Automotive, Pharmaceuticals, Others). PLUS Profiles of Leading Automatic Labelling Machine Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/automatic-labelling-machine-market/#download_sampe_div
An automatic labeling machine is designed to print-and-apply labels to…
Atomic Absorption Spectrometer Market Report Up to 2031
Visiongain has published a new report on Atomic Absorption Spectrometer Market Report to 2031: Forecasts by type (Х-rау Dіffrасtіоn Ѕресtrоmеtrу, Х-rау Fluоrеѕсеnсе Ѕресtrоmеtrу, Others), by application (Рhаrmасеutісаl, Mining Industry, Petrochemical Industry, Fооd & Веvеrаgе, Others). PLUS Profiles of Leading Atomic Absorption Spectrometer Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/atomic-absorption-spectrometer-market/#download_sampe_div
Atomic absorption spectrometer is the determination of elemental composition and is…
More Releases for Inhibitors
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Regist …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
Tumor Necrosis Factor Inhibitors Market & TNF Inhibitors Clinical Pipeline Outlo …
The search for the effective therapeutic approaches in the modulation of the TNF has been focus of the research efforts. Approximately 1 Million people in the worldwide either undergoing the treatment or have been treated with the TNF inhibitors which are available in the pharmaceutical market which surrounding the indications that include the rheumatoid arthritis, psoriatic arthritis, psoriasis and inflammatory bowel diseases.
The neutralization of the TNF signaling can be achieved…
